Advertisement

Personalized Medicine and Bladder Cancer with Dr. Matthew Milowsky – Episode 8

Published on: 

Advocacy Groups | <b>Bladder Cancer Advocacy Network</b>

Host Rick Bangs interviews Dr. Matthew Milowsky about genetics, genomics and personalized medicine for bladder cancer treatment.

In Episode 8 of “Bladder Cancer Matters,” host Rick Bangs interviews Dr. Matthew Milowsky about genetics, genomics and personalized medicine for bladder cancer treatment.

Dr. Milowsky is the Section Chief, Genitourinary Oncology; Co-Director, Urologic Oncology Program University of North Carolina School of Medicine. Dr. Milowsky is also the chair of the Bladder Cancer Genomics Consortium.

In this episode, Rick and Dr. Kamat discuss:

  • What the Bladder Cancer Genomics Consortium is and what it does
  • What an “exceptional responder” is is bladder cancer
  • The importance of clinical studies to the future of bladder cancer
  • How philanthropy propels bladder cancer medical research

Listen Here


Advertisement
Advertisement